Lomaira™ (phentermine HCl) 8 mg Tablets CIV is a prescription medicine that was submitted to FDA for approval. KVK expects FDA-approval of Lomaira in the short term.
Due to strict FDA regulations, KVK is not permitted to state the indication (the disease Lomaira treats) until it is approved for the U.S. market.
Please sign up for alerts and you will be notified when the product is approved and provided detailed information at that time. You will be able to unsubscribe at any time.
Sign up to receive the latest updates and information